WO2026080385A1 - Protéines bactériennes conférant un risque de polyarthrite rhumatoïde et méthodes et matériaux associés - Google Patents

Protéines bactériennes conférant un risque de polyarthrite rhumatoïde et méthodes et matériaux associés

Info

Publication number
WO2026080385A1
WO2026080385A1 PCT/US2025/049663 US2025049663W WO2026080385A1 WO 2026080385 A1 WO2026080385 A1 WO 2026080385A1 US 2025049663 W US2025049663 W US 2025049663W WO 2026080385 A1 WO2026080385 A1 WO 2026080385A1
Authority
WO
WIPO (PCT)
Prior art keywords
subject
peptide
cells
strain
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/US2025/049663
Other languages
English (en)
Inventor
Kristine KUHN
V. Michael Holers
Jane HOYT BUCKNER
Eddie JAMES
Brendan ALLEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virginia Mason Medical Center
University of Colorado System
University of Colorado Colorado Springs
Original Assignee
Virginia Mason Medical Center
University of Colorado System
University of Colorado Colorado Springs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Mason Medical Center, University of Colorado System, University of Colorado Colorado Springs filed Critical Virginia Mason Medical Center
Publication of WO2026080385A1 publication Critical patent/WO2026080385A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des méthodes de détection de sujets présentant un risque de développer une polyarthrite rhumatoïde, et de sujets présentant un début de polyarthrite rhumatoïde, permettant ainsi une intervention précoce. L'invention concerne des compositions pour induire une tolérance immunitaire chez un sujet, et ainsi traiter ou ralentir la progression de la PR. L'invention concerne en outre des trousses utiles pour le diagnostic de la PR.
PCT/US2025/049663 2024-10-07 2025-10-06 Protéines bactériennes conférant un risque de polyarthrite rhumatoïde et méthodes et matériaux associés Pending WO2026080385A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202463704238P 2024-10-07 2024-10-07
US63/704,238 2024-10-07

Publications (1)

Publication Number Publication Date
WO2026080385A1 true WO2026080385A1 (fr) 2026-04-16

Family

ID=99439680

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2025/049663 Pending WO2026080385A1 (fr) 2024-10-07 2025-10-06 Protéines bactériennes conférant un risque de polyarthrite rhumatoïde et méthodes et matériaux associés

Country Status (1)

Country Link
WO (1) WO2026080385A1 (fr)

Similar Documents

Publication Publication Date Title
EP2238241B1 (fr) Différenciation, identification et modulation sélectives de cellules th17 humaines
US20120213768A1 (en) Diagnostic and Therapeutic Uses for B Cell Maturation Antigen
Cavalcante et al. The thymus in myasthenia gravis: site of “innate autoimmunity”?
US20220152176A1 (en) Cancer biomarkers for durable clinical benefit
ES2818823T3 (es) Método de evaluación del riesgo de LMP
JP6999417B2 (ja) Ｉｂｄにおける治療標的及びバイオマーカー
US11262358B2 (en) Infiltrating immune cell proportions predict anti-TNF response in colon biopsies
CN116997663A (zh) 类风湿性关节炎发作的标志物和细胞前因
WO2018156448A1 (fr) Prédiction et traitement de la toxicité immunothérapeutique
US20150376701A1 (en) Biomarkers of autoimmune and/or chronic diseases associated with joint inflammation
US20220298234A1 (en) Macrophage diversity in regenerative, fibrotic biomaterial environments
WO2021087044A1 (fr) Procédés de prédiction de la réactivité d'un lymphome à un médicament et méthodes de traitement du lymphome
JP2010004750A (ja) 自己免疫疾患による組織傷害の発症または発症可能性の診断方法、およびその利用
US20250377365A1 (en) Methods involving detecting tnf stimulated gene 6 (tsg-6) for improving anti-tumor responses to immune therapy in cancer patients
WO2026080385A1 (fr) Protéines bactériennes conférant un risque de polyarthrite rhumatoïde et méthodes et matériaux associés
JP2013021932A (ja) 関節リウマチに対する抗ｉｌ−６受容体抗体療法の有効性の予測方法
US20170199186A1 (en) Methods of using cells associated with autoimmune disease
Marx et al. Thymoma-associated myasthenia gravis
Zhen et al. WDFY1-expressing follicular dendritic cells play a critical role in lupus development in cGVHD mouse model
Valma Antigen Specific CD4+ T cells and their role in viral infection and autoimmune disease
US9732320B2 (en) Selective differentiation, identification, and modulation of human TH17 cells
Tamaki et al. Gain-of-function mutation in SKAP2 leads to type 1 diabetes and broader autoimmunity through hyperactive integrin signaling in myeloid cells
Michael et al. Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis
Smith The Role of CXCL10 in the Pathogenesis of Rheumatoid Arthritis Joint Damage
WO2008100217A1 (fr) Polymorphismes des gènes de l'inflammasome cryopyrine et leurs utilisations dans le traitement des maladies inflammatoires